A-One Steels made a positive debut on the stock exchanges on Thursday, October 1, 2026, with its shares listing at a 12.35% premium on the NSE. The stock opened at ₹455 per share on the NSE, against the IPO issue price of ₹405. On the BSE, the shares began trading at ₹462, registering a 14.07% premium over the issue price.
The company’s ₹405 crore IPO was open for subscription from September 24 to September 28, 2026. The issue attracted strong investor participation and was subscribed 11.61 times by the end of the bidding period.
Explore other Upcoming IPOs on BSE and NSE.
[September 28, 2026, 7:00 PM]
|
Category |
Subscription (x) |
|
Qualified Institutional Buyers (QIBs) |
7.30x |
|
Non-Institutional Investors (NIIs) |
24.51x |
|
Retail Individual Investors (RIIs) |
8.64x |
|
Total |
11.61x |
The company intends to utilise the net proceeds from the fresh issue towards:
Established in 2012, A-One Steels India Limited is a backward-integrated steel manufacturer operating in southern India. The company manufactures a range of long and flat steel products, along with industrial materials used in steel production. Its product portfolio includes sponge iron, MS billets, TMT bars, hot-rolled and cold-rolled coils, pipes and galvanised tubes.
A-One Steels operates six manufacturing facilities across Karnataka and Andhra Pradesh, with units in Gauribidanur, Hindupur, Chikkantapur, Bellary and Koppal. Its integrated manufacturing model enables the company to maintain greater control over raw materials and intermediate products while reducing reliance on external suppliers. It serves customers across the construction, infrastructure, power, transportation and industrial sectors.
|
Particulars |
FY26 (in ₹ crore) |
FY25 (in ₹ crore) |
FY24 (in ₹ crore) |
|
Revenue from operations |
4,167.33 |
3,544.37 |
3,835.93 |
|
EBITDA |
303.64 |
174.41 |
172.19 |
|
Profit After Tax (PAT) |
127.41 |
7.71 |
38.91 |
Disclaimer: This news is solely for educational purposes. The securities/investments quoted here are not recommendatory.
To read the RA disclaimer, please click here